"Altasciences LA is a full-service CRO offering clinical development services to the pharmaceutical, biotechnology, and medical device industries. As a drug development partner, Altasciences LA collaborates with domestic and foreign innovator companies who need regulatory, program management, and strategic consulting support."

During the past decade, Altasciences conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Altasciences" #1 sponsor was "Qpex Biopharma, Inc." with 4 trials, followed by "Vaxart" with 2 trials sponsored, "Antios Therapeutics, Inc" with 1 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored and "Healthgen Biotechnology Corp." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Altasciences" #1 collaborator was "Biomedical Advanced Research and Development Authority" with 4 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Altasciences" are "Bacterial Infections" (4 trials), "Norovirus Infections" (2 trials), "Chronic Hepatitis b" (1 trials), "Emphysema Secondary to Congenital AATD" (1 trials) and "Healthy Adults" (1 trials). Many other conditions were trialed in "Altasciences" in a lesser frequency.

Most popular intervention types in "Altasciences" are "Drug" (8 trials), "Biological" (2 trials), "Other" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "QPX2014" (2 trials), "QPX7728" (2 trials), "VXA-G1.1-NN" (2 trials) and "ATI-2173 50 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Altasciences" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Altasciences". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Altasciences, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Altasciences, 9 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".